SEC Tracker
Get the app
OBIO · XBRL financial data

Orchestra BioMed Holdings financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (OBIO's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue419262*620778987253*868836861year only11088
Cost of revenue4147*34446858*44464951*3225
Research and development8,5588,511*9,11211,12611,59510,971*13,48213,85314,02716,823*15,78116,590
Selling, general and administrative6,3444,185*5,8976,4675,6665,901*6,2636,2647,0987,289*6,3735,829
Other operating income (expense)1,208(337)*960879916522*166(36)(515)(509)*1,385(1,399)
Operating income (loss)(14,524)(12,481)*(14,423)(16,859)(16,342)(16,677)*(18,921)(19,327)(20,313)6,754*(22,076)(22,356)
Interest expense4690*000297*——————
Other income (expense)——(11)0*0*0*——————
Income tax expense (benefit)—————————year only——
Net income (loss)(13,316)(12,818)*(13,463)(15,980)(15,426)(16,155)*(18,755)(19,363)(20,828)6,245*(20,691)(23,755)
Earnings per share, basic USD per share(0.38)(0.36)*(0.38)(0.45)(0.41)(0.42)*(0.49)(0.50)(0.40)—(0.33)(0.38)
Earnings per share, diluted USD per share(0.38)(0.36)*(0.38)(0.45)(0.41)(0.42)*(0.49)(0.50)(0.40)—(0.33)(0.38)
Weighted average shares, basic thousands of shares35,24435,294*35,77835,80037,62138,062*38,23538,39352,187—62,72263,812
Weighted average shares, diluted thousands of shares35,24435,294*35,77835,80037,62138,062*38,23538,39352,187—62,72263,812

Balance sheet

CSV

Fiscal quarters (OBIO's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents19,07830,55923,32423,71325,60522,26118,34818,74942,01234,69028,36720,472
Marketable securities89,41056,96851,69141,46841,32144,55131,53615,17553,80871,82266,03389,491
Marketable securities, non-current——17,40012,7005,6003,3001,9001,3004,1004,9003,4007,100
Accounts receivable8699678011592898352958451
Inventory13714611570234173135185365310277250
Prepaid and other current assets1,1161,2741,2091,1501,2782,0941,7951,6901,5319941,448977
Total current assets110,18989,11476,42966,48168,55369,17151,90335,88297,768107,91196,209111,241
Property and equipment, net1,3551,2791,3091,2351,2541,3841,4131,3661,5951,7151,8482,045
Right-of-use asset1,7141,5551,5011,3311,7142,1031,9561,8061,6531,4961,3371,171
Total assets116,35795,21282,62872,38375,31976,17359,05142,825104,807114,857100,658115,700
Accounts payable3,1502,9003,3546,2734,7235,1345,5635,3088,4736,0956,3136,132
Accrued liabilities4,3015,1493,5264,2257,0346,0845,3926,6506,8379,8906,5946,531
Total current liabilities21,47311,20810,41614,50416,21816,20715,48917,06120,65516,73613,69213,471
Lease liability, non-current1,1171,0381,1591,1021,4431,6871,5161,3281,135936730520
Total liabilities36,70127,16925,44028,25829,10043,21542,19442,53061,06851,47949,69386,280
Accumulated deficit(236,036)(248,854)(262,317)(278,297)(293,723)(309,878)(328,633)(347,996)(368,824)(362,579)(383,270)(407,025)
Total liabilities and equity116,35795,21282,62872,38375,31976,17359,05142,825104,807114,857100,658115,700
Common shares outstanding (cover page) thousands of shares35,74435,77735,78837,82538,01438,31338,31353,95556,46558,52159,88160,105

Cash flows

CSV

Fiscal quarters (OBIO's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(13,316)(12,818)*(13,463)(15,980)(15,426)(16,155)*(18,755)(19,363)(20,828)6,245*(20,691)(23,755)
Stock-based compensation3,510*919*2,5882,761*2,364*2,902*2,9653,250*3,013*2,750*2,8512,505*
Depreciation and amortization71*72*7474*76*84*8381*81*82*9096*
Net cash from operating activities(10,282)*(10,974)*(13,114)(10,206)*(13,700)*(13,538)*(16,616)(15,527)*(14,550)*(2,270)*(22,168)(19,332)*
Purchases of property and equipment19*(3)*8107*68*106*11234*310*33*184254*
Net cash from investing activities12,947*33,151*5,86110,424*557*(3,753)*12,99916,356*(38,584)*(17,712)*10,318(23,309)*
Repayments of long-term debt—year only——————————
Net cash from financing activities4*(10,696)*18171*15,035*13,947*(296)(428)*76,397*12,660*5,52734,746*
Net change in cash2,669*11,481*(7,235)389*1,892*(3,344)*(3,913)401*23,263*(7,322)*(6,323)(7,895)*

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Orchestra BioMed Holdings20,47288(19,332)*60.1M5.7 quarters 10-QJun 30, 2026
Myomo11,21911,705(1,944)*39.6M6.9 quarters 10-QJun 30, 2026
Edap TMS21,54213,203(3,691)*37.5M6.5 quarters 10-QJun 30, 2026
InspireMD15,1491,771(10,895)*46.5M2.8 quarters 10-QJun 30, 2026
Cytosorbents4,4139,633(583)*62.8M7.6 quarters 10-QJun 30, 2026
Pro Dex11,75920,5606,4903.2M— 10-QSep 30, 2026
Monogram Technologies12,834not reported(2,297)*40.6M5.6 quarters 10-QJun 30, 2025
Sensus Healthcare15,1862,290(3,133)*16.5M4.8 quarters 10-QJun 30, 2026
Spectral AI14,0003,524(4,097)*32.2M3.4 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.